Given that the patient data demonstrate heterogeneity of ERG expression in TMPRSS2:ERG positive prostate cancer, we cannot completely exclude the possibility that VDR-mediated induction of ERG will cause an increase in ERG activity in cells with low basal levels of TMPRSS2:ERG expression. The gene discussed is VDR; the disease is prostate carcinoma.